Literature DB >> 6430462

Analysis of immune responses in genital tracts of mice immunised with purified ribosomal fractions of Neisseria gonorrhoeae.

E Kita, S Kashiba.   

Abstract

Immunisation of ddY mice with the purified ribosomal fraction of Neisseria gonorrhoeae was found to protect against intravaginal challenge with homologous organisms. This protection correlated with the presence of bactericidal antibody to purified ribosomal fraction in serum as well as in vaginal secretions. Analysis of the vaginal fluids from control mice and those immunised with purified ribosomal fraction showed that the enhanced elimination of gonococci in immune mice might be because of an early response of leucocytes generated by the reaction mediated by antibody and complement. Absorption studies showed that there was at least one major protective antigen in purified ribosomal fraction, other than cell surface substances such as lipopolysaccharide, outer membrane proteins, and pili. Bactericidal assays mediated by antibody and complement showed that matched samples of serum and vaginal fluid from immune mice had comparable gonococcidal activity, which was augmented by the effect of progesterone. Although delayed hypersensitivity was produced in immune mice that were resistant to N gonorrhoeae, the exact role of cellular immunity could not be clarified in this study. These results suggest that antibody to purified ribosomal fraction plays a major part in protection against gonococcal infection in the genital tract, and that such protection may entail both cellular immunity and hormonal changes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6430462      PMCID: PMC1046313          DOI: 10.1136/sti.60.4.219

Source DB:  PubMed          Journal:  Br J Vener Dis        ISSN: 0007-134X


  20 in total

1.  Chlamydia A in the female genital tract.

Authors:  A L Hilton; S J Richmond; J D Milne; F Hindley; S K Clarke
Journal:  Br J Vener Dis       Date:  1974-02

2.  Extraction and isolation of individual ribosomal proteins from Escherichia coli.

Authors:  S Fogel; P S Sypherd
Journal:  J Bacteriol       Date:  1968-08       Impact factor: 3.490

3.  Role of outer envelope contamination in protection elicited by ribosomal preparations against Neisseria gonorrhoeae infection.

Authors:  M D Cooper; M J Wannemuehler; R D Miller; M F Fedyk
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

4.  Transfer of gonococcal urethritis from man to chimpanzee. An animal model for gonorrhea.

Authors:  C T Lucas; F Chandler; J E Martin; J D Schmale
Journal:  JAMA       Date:  1971-06-07       Impact factor: 56.272

5.  Preservation of Neisseria gonorrhoeae by the gelatin-disc method.

Authors:  S Yamai; Y Obara; T Nikkawa; Y Shimoda; Y Miyamoto
Journal:  Br J Vener Dis       Date:  1979-04

6.  Chicken embryo as an animal model for gonorrhea.

Authors:  R S Foster; J W Vinson
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

7.  Effect of progesterone on Neisseria gonorrhoeae.

Authors:  S A Morse; T J Fitzgerald
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

8.  Effect of estradiol on chlamydial genital infection of female guinea pigs.

Authors:  R G Rank; H J White; A J Hough; J N Pasley; A L Barron
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

9.  NEISSERIA GONORRHOEAE. I. VIRULENCE GENETICALLY LINKED TO CLONAL VARIATION.

Authors:  D S KELLOGG; W L PEACOCK; W E DEACON; L BROWN; D I PIRKLE
Journal:  J Bacteriol       Date:  1963-06       Impact factor: 3.490

10.  The differential susceptibility of gonococcal opacity variants to sex hormones.

Authors:  I E Salit
Journal:  Can J Microbiol       Date:  1982-03       Impact factor: 2.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.